Strategic collaborations are an important part of our business, whether we are partnering our PharmFilm® technology or in-licensing adjacent assets. We are proud of building market-leading brands that have and continue to meet the highest standards for quality, safety, and compliance.
to meet unmet needs
Aquestive and Indivior jointly developed SUBOXONE® (buprenorphine and naloxone) Sublingual Film in less than four years. As the market leader, SUBOXONE® has never experienced an out-of-stock occurrence since its launch in 2010. Learn more at suboxone.com.
Aquestive partnered with Midatech to launch ZUPLENZ® (ondansetron) oral soluble film, a PharmFilm®-technology-based formulation of ondansetron. By dissolving on the tongue, ZUPLENZ® provides an alternative for people who have difficulty in swallowing. Aquestive has been manufacturing ZUPLENZ® since 2010. Learn more at zuplenz.com